August 26, 2010 at 10:49 AM EDT
Exelixis, Cereplast gain; drug indexes split
Shares of Exelixis gain ground a day after regulatory filings revealed that two of its top execs made substantial purchases of the biotech company's stock.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here